{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:33:16Z","timestamp":1787614396935,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["201903D321153"],"award-info":[{"award-number":["201903D321153"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10549-023-07183-9","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T21:02:20Z","timestamp":1702587740000},"page":"223-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study"],"prefix":"10.1007","volume":"204","author":[{"given":"Miaomiao","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-0704","authenticated-orcid":false,"given":"Fan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"7183_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500\u2013515. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"key":"7183_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21253","volume":"65","author":"SF Shaitelman","year":"2015","unstructured":"Shaitelman SF, Cromwell KD, Rasmussen JC et al (2015) Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 65:55\u201381. https:\/\/doi.org\/10.3322\/caac.21253","journal-title":"CA Cancer J Clin"},{"key":"7183_CR3","doi-asserted-by":"publisher","first-page":"C589","DOI":"10.1152\/ajpcell.00535.2009","volume":"299","author":"T Avraham","year":"2010","unstructured":"Avraham T, Yan A, Zampell JC et al (2010) Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol 299:C589-605. https:\/\/doi.org\/10.1152\/ajpcell.00535.2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"7183_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF et al (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16:1959\u20131972. https:\/\/doi.org\/10.1245\/s10434-009-0452-2","journal-title":"Ann Surg Oncol"},{"key":"7183_CR5","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/j.clbc.2017.06.003","volume":"18","author":"S Park","year":"2018","unstructured":"Park S, Lee JE, Yu J et al (2018) Risk factors affecting breast cancer-related lymphedema: serial body weight change during neoadjuvant anthracycline plus cyclophosphamide followed by taxane. Clin Breast Cancer 18:e49\u2013e54. https:\/\/doi.org\/10.1016\/j.clbc.2017.06.003","journal-title":"Clin Breast Cancer"},{"key":"7183_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","volume":"86","author":"M Kim","year":"2013","unstructured":"Kim M, Kim SW, Lee SU et al (2013) A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys 86:498\u2013503. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7183_CR7","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/PRS.0b013e31826d0faa","volume":"130","author":"A Card","year":"2012","unstructured":"Card A, Crosby MA, Liu J et al (2012) Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone. Plast Reconstr Surg 130:1169\u20131178. https:\/\/doi.org\/10.1097\/PRS.0b013e31826d0faa","journal-title":"Plast Reconstr Surg"},{"key":"7183_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jan.15005","volume":"78","author":"P Mart\u00ednez-Jaimez","year":"2022","unstructured":"Mart\u00ednez-Jaimez P, Armora Verd\u00fa M, Forero CG et al (2022) Breast cancer-related lymphoedema: risk factors and prediction model. J Adv Nurs 78:765\u2013775. https:\/\/doi.org\/10.1111\/jan.15005","journal-title":"J Adv Nurs"},{"key":"7183_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4143\/crt.2014.079","volume":"47","author":"M Kim","year":"2015","unstructured":"Kim M, Park IH, Lee KS et al (2015) Breast cancer-related lymphedema after neoadjuvant chemotherapy. Cancer Res Treat 47:416\u2013423. https:\/\/doi.org\/10.4143\/crt.2014.079","journal-title":"Cancer Res Treat"},{"key":"7183_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2019.101720","volume":"44","author":"M Thomas","year":"2020","unstructured":"Thomas M, Coveney E, Pike C et al (2020) Exploring the impact of lymphoedema on individuals and if lymphatic venous anastomosis surgery effects perceptions on quality of life: a qualitative study. Eur J Oncol Nurs 44:101720. https:\/\/doi.org\/10.1016\/j.ejon.2019.101720","journal-title":"Eur J Oncol Nurs"},{"key":"7183_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/cancers12030565","volume":"12","author":"M Coriddi","year":"2020","unstructured":"Coriddi M, Dayan J, Sobti N et al (2020) Systematic review of patient-reported outcomes following surgical treatment of lymphedema. Cancers (Basel) 12:565. https:\/\/doi.org\/10.3390\/cancers12030565","journal-title":"Cancers (Basel)"},{"key":"7183_CR12","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483\u20132493. https:\/\/doi.org\/10.1200\/JCO.1997.15.7.2483","journal-title":"J Clin Oncol"},{"key":"7183_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2214\/AJR.17.18295","volume":"210","author":"HT Le-Petross","year":"2018","unstructured":"Le-Petross HT, McCall LM, Hunt KK et al (2018) Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol 210:669\u2013676. https:\/\/doi.org\/10.2214\/AJR.17.18295","journal-title":"AJR Am J Roentgenol"},{"key":"7183_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang C-S, Mano MS et al (2019) Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380:617\u2013628. https:\/\/doi.org\/10.1056\/NEJMoa1814017","journal-title":"N Engl J Med"},{"key":"7183_CR15","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee S-J, Ohtani S et al (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376:2147\u20132159. https:\/\/doi.org\/10.1056\/NEJMoa1612645","journal-title":"N Engl J Med"},{"key":"7183_CR16","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","volume":"28","author":"G Curigliano","year":"2017","unstructured":"Curigliano G, Burstein HJ, Winer EP et al (2017) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol 28:1700\u20131712. https:\/\/doi.org\/10.1093\/annonc\/mdx308","journal-title":"Ann Oncol"},{"key":"7183_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV et al (2014) Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg 260:608\u2013614. https:\/\/doi.org\/10.1097\/SLA.0000000000000924","journal-title":"Ann Surg"},{"key":"7183_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-014-3137-x","volume":"148","author":"S-Y Jung","year":"2014","unstructured":"Jung S-Y, Shin KH, Kim M et al (2014) Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients. Breast Cancer Res Treat 148:91\u201398. https:\/\/doi.org\/10.1007\/s10549-014-3137-x","journal-title":"Breast Cancer Res Treat"},{"key":"7183_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamasurg.2019.1742","volume":"154","author":"JM Armer","year":"2019","unstructured":"Armer JM, Ballman KV, McCall L et al (2019) Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection. JAMA Surg 154:800\u2013809. https:\/\/doi.org\/10.1001\/jamasurg.2019.1742","journal-title":"JAMA Surg"},{"key":"7183_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10549-013-2655-2","volume":"140","author":"MC Specht","year":"2013","unstructured":"Specht MC, Miller CL, Russell TA et al (2013) Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat 140:485\u2013494. https:\/\/doi.org\/10.1007\/s10549-013-2655-2","journal-title":"Breast Cancer Res Treat"},{"key":"7183_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/lrb.2005.3.208","volume":"3","author":"JM Armer","year":"2005","unstructured":"Armer JM, Stewart BR (2005) A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol 3:208\u2013217. https:\/\/doi.org\/10.1089\/lrb.2005.3.208","journal-title":"Lymphat Res Biol"},{"key":"7183_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jss.2016.11.009","volume":"210","author":"X Li","year":"2017","unstructured":"Li X, Huang H, Lin Q et al (2017) Validation of a breast cancer nomogram to predict lymphedema in a Chinese population. J Surg Res 210:132\u2013138. https:\/\/doi.org\/10.1016\/j.jss.2016.11.009","journal-title":"J Surg Res"},{"key":"7183_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","volume":"8","author":"G Montagna","year":"2022","unstructured":"Montagna G, Zhang J, Sevilimedu V et al (2022) Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema. JAMA Oncol 8:1195\u20131200. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1628","journal-title":"JAMA Oncol"},{"key":"7183_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.amjsurg.2016.08.016","volume":"213","author":"MN Basta","year":"2017","unstructured":"Basta MN, Wu LC, Kanchwala SK et al (2017) Reliable prediction of postmastectomy lymphedema: the risk assessment tool evaluating lymphedema. Am J Surg 213:1125-1133.e1. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.08.016","journal-title":"Am J Surg"},{"key":"7183_CR25","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1245\/s10434-012-2828-y","volume":"20","author":"MC Specht","year":"2013","unstructured":"Specht MC, Miller CL, Skolny MN et al (2013) Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients. Ann Surg Oncol 20:2835\u20132841. https:\/\/doi.org\/10.1245\/s10434-012-2828-y","journal-title":"Ann Surg Oncol"},{"key":"7183_CR26","doi-asserted-by":"publisher","first-page":"1026043","DOI":"10.3389\/fonc.2022.1026043","volume":"12","author":"JS Kim","year":"2022","unstructured":"Kim JS, Kim JH, Chang JH et al (2022) Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis. Front Oncol 12:1026043. https:\/\/doi.org\/10.3389\/fonc.2022.1026043","journal-title":"Front Oncol"},{"key":"7183_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/jcm8020138","volume":"8","author":"M Invernizzi","year":"2019","unstructured":"Invernizzi M, Michelotti A, Noale M et al (2019) Breast cancer systemic treatments and upper limb lymphedema: a risk-assessment platform encompassing tumor-specific pathological features reveals the potential role of trastuzumab. J Clin Med 8:138. https:\/\/doi.org\/10.3390\/jcm8020138","journal-title":"J Clin Med"},{"key":"7183_CR28","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/ATVBAHA.118.310997","volume":"38","author":"F Morfoisse","year":"2018","unstructured":"Morfoisse F, Tatin F, Chaput B et al (2018) Lymphatic vasculature requires estrogen receptor-\u03b1 signaling to protect from lymphedema. Arterioscler Thromb Vasc Biol 38:1346\u20131357. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7183_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11764-014-0416-9","volume":"9","author":"N Das","year":"2015","unstructured":"Das N, Baumgartner RN, Riley EC et al (2015) Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors. J Cancer Surviv 9:422\u2013430. https:\/\/doi.org\/10.1007\/s11764-014-0416-9","journal-title":"J Cancer Surviv"},{"key":"7183_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.18632\/aging.101772","volume":"11","author":"B Garmy-Susini","year":"2019","unstructured":"Garmy-Susini B (2019) Hormone therapy outcome in lymphedema. Aging (Albany NY) 11:291\u2013292. https:\/\/doi.org\/10.18632\/aging.101772","journal-title":"Aging (Albany NY)"},{"key":"7183_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/cancers13030530","volume":"13","author":"F Morfoisse","year":"2021","unstructured":"Morfoisse F, Zamora A, Marchaud E et al (2021) Sex hormones in lymphedema. Cancers (Basel) 13:530. https:\/\/doi.org\/10.3390\/cancers13030530","journal-title":"Cancers (Basel)"},{"key":"7183_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1524-4741.2009.00703.x","volume":"15","author":"M Dayangac","year":"2009","unstructured":"Dayangac M, Makay O, Yeniay L et al (2009) Precipitating factors for lymphedema following surgical treatment of breast cancer: implications for patients undergoing axillary lymph node dissection. Breast J 15:210\u2013211. https:\/\/doi.org\/10.1111\/j.1524-4741.2009.00703.x","journal-title":"Breast J"},{"key":"7183_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/01.sla.0000259390.51203.7b","volume":"246","author":"AD Purushotham","year":"2007","unstructured":"Purushotham AD, Bennett Britton TM, Klevesath MB et al (2007) Lymph node status and breast cancer-related lymphedema. Ann Surg 246:42\u201345. https:\/\/doi.org\/10.1097\/01.sla.0000259390.51203.7b","journal-title":"Ann Surg"},{"key":"7183_CR34","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.20.00459","volume":"38","author":"GE Naoum","year":"2020","unstructured":"Naoum GE, Roberts S, Brunelle CL et al (2020) Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol 38:3430\u20133438. https:\/\/doi.org\/10.1200\/JCO.20.00459","journal-title":"J Clin Oncol"},{"key":"7183_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2021.101909","volume":"51","author":"Y-F Liu","year":"2021","unstructured":"Liu Y-F, Liu J-E, Mak YW et al (2021) Prevalence and predictors of breast cancer-related arm lymphedema over a 10-year period in postoperative breast cancer patients: a cross-sectional study. Eur J Oncol Nurs 51:101909. https:\/\/doi.org\/10.1016\/j.ejon.2021.101909","journal-title":"Eur J Oncol Nurs"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07183-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T11:19:40Z","timestamp":1710760780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7183"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07183-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3012109\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanxi Bethune Hospital (YXLL-2023\u2013114).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that the human study participants provided informed consent for the publication of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}